Sharp Edge Labs announced Monday that the company has been awarded a $156K grant from the National Institutes of Health to develop biosensor technology for measuring the levels of molecules involved in cancer. The Phase 1 SBIR grant will allow the NSIV graduate to explore the feasibility of developing immunosensors that combine antibodies for specific recognitionRead more